脑部放疗,上午比下午敏感许多!# }- k6 Z$ Z. F/ i7 V
. A8 J# r) }$ K
* W% T& O6 P5 h+ `9 L0 i* YCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
( }" K# @- E) U+ `$ kGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?$ D `/ }( W) q. j! r$ y6 V: ~
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.8 h7 [5 y+ o& r9 \- C' Y2 |% l- ]
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.8 h( ?# K$ w/ X. }, ~
* \* K& z. t4 n' D/ p" SAbstract
! k' j+ T- Q7 Z/ g1 O2 U7 hBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.* `2 x' ~0 i0 q1 r. q; C5 U
" o. P" d4 d! \* Y% }/ ]+ J
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
+ y' O5 v; E2 z/ j% r1 i+ C4 \
' Z ]0 ?9 \3 A9 WRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).$ {6 Y, _" i Z
8 [- M0 g% {/ f9 I# u* }: e
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.1 F+ R( O; p' \: Y) L
4 R* M% J! }7 R( @* T! v
|